Hospital Paulistano
Sao Paulo, Brazil
General hospital in São Paulo, State of São Paulo
R. Martiniano de Carvalho, 741 - Bela Vista, São Paulo - SP, 01321-001
About Hospital Paulistano
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Paulistano
During the past decade, Hospital Paulistano conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on
average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
2009-05-01
2010-05-01
Completed
15
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Paulistano" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored, "Hospital Moinhos de Vento" with 1 trials sponsored and "Hospital do Coracao"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Paulistano"
#1 collaborator was "Astellas Pharma Europe Ltd." with 1 trials as a collaborator, "Bactiguard AB" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian Urologic Oncology Group" with 1 trials as a collaborator and "Cancer Trials Ireland" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Hospital Paulistano
According to Clinical.Site data, the most researched conditions in "Hospital Paulistano" are
"Brain Death" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Critically Ill" (1 trials) and "Leukemia, Myelomonocytic, Chronic" (1 trials). Many other conditions were trialed in "Hospital Paulistano" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Paulistano
Most popular intervention types in "Hospital Paulistano" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Pomalidomide" (2 trials), "5-Fluorouracil" (1 trials) and "Amivantamab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Paulistano
The vast majority of trials in "Hospital Paulistano" are
10 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hospital Paulistano
Currently, there are NaN active trials in "Hospital Paulistano".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Paulistano,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Paulistano, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".